Last updated on 9 May 2024
Owner Info
Alexion Pharmaceuticals, Inc.
121 Seaport Boulevard
Boston MA 02210, UNITED STATES OF AMERICA
Serial Number
2330089 filed on 21 Dec 2022
Correspondent
Dennemeyer & Associates S.A.
55 rue des Bruyères,
L-1274 Howald,
LUXEMBOURG
2330089
21 Dec 2022
21 Dec 2032
WORD
22 Jul 2022
US
Status Date | Action Taken |
---|---|
9th May 2024 | Amendment to International Registration Contact Requested |
25th Apr 2023 | International Registration in Australia Protected correspondence sent |
24th Apr 2023 | IP Right Registration Published |
24th Apr 2023 | Status change to Registered/Protected |
16th Feb 2023 | Application Accepted correspondence sent |
15th Feb 2023 | IP Right has been Examined |
15th Feb 2023 | IP Right Acceptance Published |
15th Feb 2023 | Status change to Accepted |
2th Feb 2023 | Awaiting examination |
2th Feb 2023 | Examination expedited |